NCT05677438: A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia |
|
|
| Completed | 2 | 121 | RoW | CKD-498 dose#1, CKD-498 dose#2, CKD-498 dose#3, Placebo of CKD-498 dose#1, Placebo of CKD-498 dose#2, Placebo of CKD-498 dose#3 | Chong Kun Dang Pharmaceutical | Androgenetic Alopecia | 12/23 | 12/23 | | |
